Pharmaceutical
| Mon 18 May 2026
Beijing, May 19 -- Shanghai Qilu Pharmaceutical Res Center Co Ltd has applied Chinese patent for Kat6 Inhibitors. Yang Chundao, Zheng Xuejian, Zhang Fumao, Qian Wenyuan, Shi Guqin, Zhang Yuxing, Guo Huijie, Sun Weimei, Sun Daqing and Tao Weikang developed it.
The patent application number is CN20248036589 20240703. The patent..